Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,088 | 11,977 | 14,217 | 14,750 | 18,810 |
| Marketable Securities | 1,578 | 1,602 | 1,621 | 1,523 | 1,610 |
| Receivables | 41 | 35 | 42 | 44 | 260 |
| Other current assets | 0 | 0 | 0 | 0 | 410 |
| TOTAL | $10,904 | $13,887 | $16,292 | $16,484 | $21,090 |
| Non-Current Assets | |||||
| PPE Net | 242 | 256 | 289 | 300 | 1,290 |
| TOTAL | $242 | $256 | $289 | $300 | $1,290 |
| Total Assets | $11,146 | $14,143 | $16,581 | $16,784 | $21,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,073 | 2,155 | 2,158 | 1,862 | 2,120 |
| TOTAL | $3,073 | $2,155 | $2,158 | $1,862 | $2,120 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,073 | $2,155 | $2,158 | $1,862 | $2,120 |
| Shareholders' Equity | |||||
| Common Shares | 198,105 | 201,148 | 203,293 | 190,432 | 204,740 |
| Retained earnings | -210,572 | -209,893 | -209,743 | -195,158 | -206,600 |
| Other shareholders' equity | 419 | 378 | 357 | 431 | 610 |
| TOTAL | $8,073 | $11,988 | $14,424 | $14,922 | $19,330 |
| Total Liabilities And Equity | $11,146 | $14,143 | $16,581 | $16,784 | $21,450 |